Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 40 results.
User Information
Export Records
  1. 1.   Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
  2. Basudhar, Debashree; Miranda, Katrina M.; Wink, David; Ridnour, Lisa
  3. REDOX-ACTIVE THERAPEUTICS. 2016; : 377-403.
  1. 2.   The antishock effect of anisodamine requires the upregulation of alpha 7 nicotine acetylcholine receptors by IL-10
  2. Li, Q.; Lei, H.; Liu, A. J.; Yang, Y. L.; Su, D. F.; Liu, X.
  3. Life Sciences. 2011, Sep; 89(11-12): 395-401.
  1. 3.   A Distal Enhancer in Il12b Is the Target of Transcriptional Repression by the STAT3 Pathway and Requires the Basic Leucine Zipper (B-ZIP) Protein NFIL3
  2. Smith, A. M.; Qualls, J. E.; O'Brien, K.; Balouzian, L.; Johnson, P. F.; Schultz-Cherry, S.; Smale, S. T.; Murray, P. J.
  3. Journal of Biological Chemistry. 2011, Jul; 286(26): 23582-23590.
  1. 4.   Novel Chalcone Derivatives as Potent Nrf2 Activators in Mice and Human Lung Epithelial Cells
  2. Kumar, V.; Kumar, S.; Hassan, M.; Wu, H. L.; Thimmulappa, R. K.; Kumar, A.; Sharma, S. K.; Parmar, V. S.; Biswal, S.; Malhotra, S. V.
  3. Journal of Medicinal Chemistry. 2011, Jun; 54(12): 4147-4159.
  1. 5.   Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Colburn, N. H.; Cross, A. J.
  3. British Journal of Cancer. 2010, Oct; 103(9): 1453-1461.
  1. 6.   Profiling of cell cycle genes of breast cells exposed to etodolac
  2. Roy, D.; Arason, G. A.; Chowdhury, B.; Mitra, A.; Calaf, G. M.
  3. Oncology Reports. 2010, May; 23(5): 1383-1391.
  1. 7.   PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
  2. Dossus, L.; Kaaks, R.; Canzian, F.; Albanes, D.; Berndt, S. I.; Boeing, H.; Buring, J.; Chanock, S. J.; Clavel-Chapelon, F.; Feigelson, H. S.; Gaziano, J. M.; Giovannucci, E.; Gonzalez, C.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hayes, R. B.; Henderson, B. E.; Hoover, R. N.; Hunter, D. J.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Ma, J.; Le Marchand, L.; Lund, E.; Peeters, P. H. M.; Stampfer, M.; Stram, D. O.; Thomas, G.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Riboli, E.; Virtamo, J.; Weinstein, S. J.; Yeager, M.; Ziegler, R. G.; Cox, D. G.
  3. Carcinogenesis. 2010, Mar; 31(3): 455-461.
  1. 8.   Nuclear Accumulation of beta-Catenin Protein Indicates Activation of wnt Signaling in Chemically Induced Rat Nephroblastomas
  2. Ehrlich, D.; Bruder, E.; Thome, M. A.; Gutt, C. N.; Doeberitz, M. V.; Niggli, F.; Perantoni, A. O.; Koesters, R.
  3. Pediatric and Developmental Pathology. 2010, Jan-Feb; 13(1): 1-8.
  1. 9.   Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence-Data from a Randomized Clinical Trial
  2. Barry, E. L.; Sansbury, L. B.; Grau, M. V.; Ali, I. U.; Tsang, S.; Munroe, D. J.; Ahnen, D. J.; Sandler, R. S.; Saibil, F.; Gui, J.; Bresalier, R. S.; McKeown-Eyssen, G. E.; Burke, C.; Baron, J. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(10): 2726-2733.
  1. 10.   Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation
  2. MacDonald, C. J.; Cheng, R.; Roberts, D. D.; Wink, D. A.; Yeh, G. C.
  3. Journal of Biological Chemistry. 2009 284(33): 22099-22107.
  1. 11.   Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA
  2. Chakrabarti, A.; Sadler, A. J.; Kar, N.; Young, H. A.; Silverman, R. H.; Williams, B.
  3. Journal of Biological Chemistry. 2008 283(37): 25132-25139.
  1. 12.   Second-generation aspirin and indomethacin prodrugs possessing an O-2-(Acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation, and nitric oxide release studies
  2. Velazquez, C. A.; Chen, Q. H.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Journal of Medicinal Chemistry. 2008 51(6): 1954-1961.
  1. 13.   Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer
  2. Daugherty, S. E.; Shugart, Y. Y.; Platz, E. A.; Fallin, M. D.; Isaacs, W. B.; Pfeiffer, R. M.; Welch, R.; Huang, W. Y.; Reding, D.; Hayes, R. B.
  3. Prostate. 2007, Oct; 67(14): 1487-1497.
  1. 14.   Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma
  2. Daugherty, S. E.; Platz, E. A.; Shugart, Y. Y.; Fallin, M. D.; Isaacs, W. B.; Chatterjee, N.; Welch, R.; Huang, W. Y.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Aug; 16(8): 1536-1542.
  1. 15.   O-2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies
  2. Velazquez, C. A.; Rao, P. N. P.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Bioorganic & Medicinal Chemistry. 2007, Jul; 15(14): 4767-4774.
  1. 16.   AP-1 a target for cancer prevention
  2. Matthews, C. P.; Colburn, N. H.; Young, M. R.
  3. Current Cancer Drug Targets. 2007, Jun; 7(4): 317-324.
  1. 17.   Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro
  2. Ciolino, H. P.; MacDonald, C. J.; Memon, O. S.; Bass, S. E.; Yeh, G. C.
  3. Carcinogenesis. 2006, Aug; 27(8): 1586-1592.
  1. 18.   4,5-Diaryl-1H-pyrrole-2-carboxylates as combretastatin A-4/lamellarin T hybrids: Synthesis and evaluation as anti-mitotic and cytotoxic agents
  2. Banwell, M. G.; Hamel, E.; Hockless, D. C. R.; Verdier-Pinard, P.; Willis, A. C.; Wong, D. J.
  3. Bioorganic & Medicinal Chemistry. 2006, Jul; 14(13): 4627-4638.
  1. 19.   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
  2. Rothman, N.; Skibola, C. F.; Wang, S. S.; Morgan, G.; Lon, Q.; Smith, M. T.; Spinelli, J. J.; Willett, E.; De Sanjose, S.; Cocco, P.; Berndt, S. I.; Brennan, P.; Brooks-Wilson, A.; Wacholder, S.; Becker, N.; Hartge, P.; Zheng, T. Z.; Roman, E.; Holly, E. A.; Boffetta, P.; Armstrong, B.; Cozen, W.; Linet, M.; Bosch, F. X.; Ennas, M. G.; Holford, T. R.; Gallagher, R. P.; Rollinson, S.; Bracci, P. M.; Cerhan, J. R.; Whitby, D.; Moore, P. S.; Leaderer, B.; Lai, A.; Spink, C.; Davis, S.; Bosch, R.; Scarpa, A.; Zhang, Y. W.; Severson, R. K.; Yeager, M.; Chanock, S.; Nieters, A.
  3. Lancet Oncology. 2006, JAN; 7(1): 27-38.
  1. 20.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 21.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 22.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 23.   Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE(2) and TGF-beta(1)
  2. Ha, C. T.; Waterhouse, R.; Wessells, J.; Wu, J. A.; Dveksler, G. S.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 948-957.
  1. 24.   Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
  2. Zhan, C. L.; Correa-de-Araujo, R.; Bierman, A. S.; Sangl, J.; Miller, M. R.; Wickizer, S. W.; Stryer, D.
  3. Journal of the American Geriatrics Society. 2005, FEB; 53(2): 262-267.
  1. 25.   Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease
  2. Iribarren, P.; Zhou, Y.; Hu, J. Y.; Le, Y. Y.; Wang, J. M.
  3. Immunologic Research. 2005 31(3): 165-176.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel